This Week is Terrapinn's World Biosimilar Congress USA 2016 - last chance to book!
SAN DIEGO, May 17, 2016 /PRNewswire/ -- Over 300 Attendees from the world of biosimilars are heading to San Diego this week for the World Biosimilar Congress USA 2016, hosted by Terrapinn Inc.
- Zydus Cadila will be showcasing their strategy to enter the US market
- Steve Miller, Chief Medical Officer of Express Scripts will be explaining how to design a clinical trial for the proper status through a PBM
- The event is co-located with the Americas Antibody Congress and the Cell Culture World Congress – your ticket gets you in to all three!
BOOK your ticket now at http://goo.gl/Ll9aCu
They will be joined by hundreds of other attendees from a wide range of biopharma and biotech, including:
Amunix, XL-protein, Janssen, Novartis, GSK, Bristol-Meyers Squibb, Bio-Techne, Bioinformatics Inc., Aldevron, Trellis Biosciences, Merck & Co., Immunogen, Genentech, Curemeta, Valerion, MabVax, Regeneron, XBiotech, Mapp Pharmaceuticals, Visterra, MedImmune, Takeda, Tetralogic, Global Biological Standard Institute, NIH, Arsanis, Express Scripts, Novation/Vizient, Pfenex, Boehringer Ingelheim, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Harvest Moon Pharmaceuticals, Merck Serono, Biocon, Protein Sciences Corporation, Pfizer, Zydus Cadila, Biogen
Don't miss out – tickets will run out soon. BOOK your ticket now at http://goo.gl/Ll9aCu
See you in San Diego!
BOOK your ticket now at http://goo.gl/Ll9aCu
SOURCE Terrapinn Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article